By Dr Pallavi Bradshaw, Medical Director, and Dr Zarko Kamenica, Technical Consultant Lead – International discuss recent legislation proposing significant changes.

Dr Lucy Gibberd and Dr Mark Burns, Medicolegal Consultants at Medical Protection, discuss New Zealand’s expanded ADHD stimulant prescribing and how this may improve access but raises clinical, training, and medicolegal considerations for GPs.

Dr Lucy Gibberd, Medicolegal Consultant at Medical Protection, shares how the new IPP3A privacy rules affect clinicians and practices, including updated obligation for collecting and notifying patients about health information.

Dr Sara Jamieson, Dr Lucy Hanington, and Dr Mark Burns, all Medicolegal Consultants at Medical Protection, share how to navigate this tricky situation.

Dr Samantha King, Medicolegal Consultant at Medical Protection, shares an evidence-based overview of prescribing risks in telehealth, with practical guidance for clinicians on medication safety, regulatory standards and patient assessment.

Chao-Yuan Chen, Medicolegal Consultant at Medical Protection, addresses how health providers can respect patient preferences while also protecting staff and upholding legal and ethical obligations.